These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 32955172)

  • 41. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials.
    Patel RB; Shah SJ
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():41-63. PubMed ID: 30296895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.
    Li X; Sun M; Wang Z; Sun S; Wang Y
    Eur J Clin Invest; 2024 Mar; 54(3):e14130. PubMed ID: 38071416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and Prognostic Value of CMR T
    Rommel KP; Lücke C; Lurz P
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):848-855. PubMed ID: 28314659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart failure with preserved ejection fraction in hypertension.
    Teo LY; Chan LL; Lam CS
    Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ
    Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
    Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
    Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
    Kjeldsen SE; von Lueder TG; Smiseth OA; Wachtell K; Mistry N; Westheim AS; Hopper I; Julius S; Pitt B; Reid CM; Devereux RB; Zannad F
    Hypertension; 2020 Jan; 75(1):23-32. PubMed ID: 31786973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.
    Wang S; Xiao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1733-1739. PubMed ID: 36748385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heart failure with preserved ejection fraction assessed by cardiac magnetic resonance: From clinical uses to emerging techniques.
    He J; Yang W; Jiang Y; Sun X; Zhao S; Weiss R; Sirajuddin A; Lu M
    Trends Cardiovasc Med; 2023 Apr; 33(3):141-147. PubMed ID: 34933114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis.
    Graziani F; Varone F; Crea F; Richeldi L
    Eur J Heart Fail; 2018 Oct; 20(10):1385-1391. PubMed ID: 30085383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HBI-8000 improves heart failure with preserved ejection fraction via the TGF-β1/MAPK signalling pathway.
    Tian J; Li W; Zeng L; Li Y; Du J; Li Y; Li B; Su G
    J Cell Mol Med; 2024 Apr; 28(7):e18238. PubMed ID: 38509729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of heart failure with preserved ejection fraction: a review.
    Nanayakkara S; Kaye DM
    Clin Ther; 2015 Oct; 37(10):2186-98. PubMed ID: 26385583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.
    Bachmann JC; Baumgart SJ; Uryga AK; Bosteen MH; Borghetti G; Nyberg M; Herum KM
    Cells; 2022 May; 11(10):. PubMed ID: 35626694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.